D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
Broadcom
AVGO
|
+$1.2B |
| 2 |
Boston Scientific
BSX
|
+$1.05B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$934M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$924M |
| 5 |
JPMorgan Chase
JPM
|
+$922M |
Top Sells
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.2B |
| 2 |
NVIDIA
NVDA
|
+$1.58B |
| 3 |
Palantir
PLTR
|
+$901M |
| 4 |
Netflix
NFLX
|
+$883M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$805M |
Sector Composition
| 1 | Technology | 18.55% |
| 2 | Consumer Discretionary | 8.97% |
| 3 | Financials | 8.5% |
| 4 | Healthcare | 8.44% |
| 5 | Industrials | 7.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1151
GFL Environmental
GFL
$14.3B
| $18M | 0.01% |
431,608
+208,362
| +93% | +$8.91M |
|
1152
Zions Bancorporation
ZION
$10.6B
| $18M | 0.01% |
312,096
-59,592
| -16% | -$3.51M |
|
1153
CALL
Unity
U
$12.7B
| $18M | 0.01% |
819,500
-120,900
| -13% | -$3.35M |
|
1154
Johnson Controls International
JCI
$85.7B
| $17.9M | 0.01% |
136,986
-135,779
| -50% | -$17.5M |
|
1155
Sabra Healthcare REIT
SBRA
$5.07B
| $17.9M | 0.01% |
932,058
+275,680
| +42% | +$5.43M |
|
|
ESPR
1156
DELISTED
Esperion Therapeutics
ESPR
| $17.9M | 0.01% |
6,540,785
-362,698
| -5% | -$1.15M |
|
1157
Healthcare Realty
HR
$7.39B
| $17.9M | 0.01% |
1,054,779
+680,035
| +181% | +$11.9M |
|
1158
Hyatt Hotels
H
$18B
| $17.9M | 0.01% |
124,567
+109,238
| +713% | +$17.3M |
|
1159
Replimune Group
REPL
$859M
| $17.9M | 0.01% |
2,336,528
-238,514
| -9% | -$1.82M |
|
1160
Omnicell
OMCL
$2.09B
| $17.8M | 0.01% |
534,611
-377,343
| -41% | -$15.8M |
|
1161
PUT
Baidu
BIDU
$36.5B
| $17.8M | 0.01% |
160,000
-611,900
| -79% | -$83M |
|
1162
BioNTech
BNTX
$23.1B
| $17.8M | 0.01% |
199,768
-288,784
| -59% | -$29.7M |
|
1163
Rayonier Advanced Materials
RYAM
$555M
| $17.6M | 0.01% |
1,594,055
+55,670
| +4% | +$502K |
|
1164
Meritage Homes
MTH
$4.95B
| $17.6M | 0.01% |
285,336
+117,076
| +70% | +$8.27M |
|
1165
iShares US Medical Devices ETF
IHI
$3.03B
| $17.6M | 0.01% |
329,189
+292,088
| +787% | +$17.2M |
|
1166
Regeneron Pharmaceuticals
REGN
$70.9B
| $17.6M | 0.01% |
22,730
-132,745
| -85% | -$102M |
|
1167
Collegium Pharmaceutical
COLL
$1.17B
| $17.6M | 0.01% |
530,698
-123,176
| -19% | -$5.22M |
|
1168
Ormat Technologies
ORA
$6.43B
| $17.5M | 0.01% |
156,353
-45,384
| -22% | -$5.27M |
|
1169
Avis
CAR
$5.67B
| $17.5M | 0.01% |
119,825
-80,455
| -40% | -$9.17M |
|
1170
PUT
Flutter Entertainment
FLUT
$18.5B
| $17.4M | 0.01% |
171,100
+156,900
| +1,105% | +$22.6M |
|
1171
IAMGOLD
IAG
$8.17B
| $17.4M | 0.01% |
925,673
-1,157,941
| -56% | -$23M |
|
1172
Equifax
EFX
$21.1B
| $17.4M | 0.01% |
+96,685
| New | +$19.2M |
|
1173
WaFd
WAFD
$2.82B
| $17.3M | 0.01% |
551,847
+193,949
| +54% | +$6.24M |
|
1174
PUT
Humana
HUM
$48B
| $17.3M | 0.01% |
99,900
-89,600
| -47% | -$18.4M |
|
1175
Sensient Technologies
SXT
$4.64B
| $17.3M | 0.01% |
200,281
-3,230
| -2% | -$302K |
|
Similar funds
D.E. Shaw & Co's Q1 2026 Portfolio in Review
As of Q1 2026, D.E. Shaw & Co held 5,226 positions worth $166B, down 8.8% from $182B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
D.E. Shaw & Co withdrew a net $15.1B in Q1 2026, closing 756 positions and reducing 1,922 holdings. Its most notable exit was iShares Core S&P 500 ETF, an estimated $805M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 19% a quarter earlier, followed by Consumer Discretionary and Financials.
Against the trend, D.E. Shaw & Co opened a new position in Venture Global Inc worth $211M.
- D.E. Shaw & Co's largest Q1 2026 buy was Venture Global Inc: 13,410,074 shares worth $211M.
- D.E. Shaw & Co added most to Broadcom in Q1 2026, an estimated $1.2B increase.
- D.E. Shaw & Co's biggest Q1 2026 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $3.2B.
- D.E. Shaw & Co fully exited iShares Core S&P 500 ETF in Q1 2026, selling an estimated $805M.
- D.E. Shaw & Co's ten largest holdings make up 11% of its $166B portfolio in Q1 2026.
- D.E. Shaw & Co opened 685 new positions and closed 756 in Q1 2026.
- D.E. Shaw & Co's portfolio value fell 8.8% quarter-over-quarter to $166B.
Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.